07/20/21 11:58 AM EDT

"The Call" Recap | Healthcare Analyst Tom Tobin Highlights $NTRA

Tom Tobin

Watch below as Healthcare analyst Tom Tobin highlights Natera (NTRA), then discusses cancer testing and then comments on the Delta Variant.

(This clip is a small taste of what our subscribers get each day on The Call @ Hedgeye. In a nutshell, The Call is our morning research call hosted by Hedgeye CEO Keith McCullough with our 40+ analyst research team. It helps small and large investors alike make better decisions via unique and investable stock/sector updates Click here to learn more.)

"The Call" Recap | Healthcare Analyst Tom Tobin Highlights $NTRA

Stock Spotlight: Hubspot Gains +36% in Under 90 Days—Why We're Still Bullish

TPB Has Doubled Since June—Why It's Still a Great Opportunity

Meet The Team Behind the Stock Picks: Our Triple-Tested Process

How To Use our Stock Signals to Invest Like a Pro

Important: Which Stocks Should You Buy or Short?

The $REAL Deal: Hedgeye "Best Idea" Scores Massive 400% Win

Stock Spotlight: Hubspot Gains +36% in Under 90 Days—Why We're Still Bullish

Macro Monday 12/16/24: Inflation is Back, and Consensus is Catching Up

What Most Investors Get Wrong About Market Crashes—and How You Can Avoid the Next One

Know When to Get Out: Staying Ahead of Market Crashes

Cartoon of the Day: When Hell Freezes Over

Cartoon of the Day

CHART OF THE DAY: Racing In The Rain + OODA (Observe, Orient, Decide, Act) Loop

Cartoon of the Day: Laughingstock

CHART OF THE DAY: Historic Volatility (One of the Largest $VIX Spikes Ever)

Feeling the Squeeze: How Surging Inflation is Affecting Everyday Life

Sign up for free: Hedgeye's Market Brief